| Asset | 30 Sep 2026 | 31 Aug 2026 | 31 Jul 2026 | 30 Jun 2026 | 31 May 2026 | 30 Apr 2026 |
|---|---|---|---|---|---|---|
| Equity | 97.31% | 97.99% | 97.32% | 97.64% | 97.98% | 98.70% |
| Debt | 0.02% | 0.01% | 0.01% | 0.01% | 0.00% | 0.01% |
| Others (incl. cash) | 2.67% | 2.00% | 2.67% | 2.35% | 2.02% | 1.29% |
| Commodities | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Real Estate | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Instrument | Sector | No. of Shares | Value (Rs. Cr) | Weight | Change |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Healthcare | 59,06,349 | 1,072.95 | 11.71% | -0.66%↓ |
| Divis Laboratories Ltd. | Healthcare | 7,00,754 | 651.11 | 7.10% | 0.10%↑ |
| Lupin Ltd. | Healthcare | 27,83,991 | 565.21 | 6.17% | -0.26%↓ |
| Cipla Ltd. | Healthcare | 40,95,054 | 551.19 | 6.01% | -0.08%↓ |
| Dr. Reddys Laboratories Ltd. | Healthcare | 40,49,746 | 499.33 | 5.45% | 0.52%↑ |
| Apollo Hospitals Enterprise Ltd. | Healthcare | 5,48,795 | 448.12 | 4.89% | -0.26%↓ |
| Mankind Pharma Ltd. | Healthcare | 16,03,562 | 401.5 | 4.38% | 0.29%↑ |
| Sai Life Sciences Ltd. | Healthcare | 23,55,745 | 359.13 | 3.92% | -0.02%↓ |
| Ajanta Pharma Ltd. | Healthcare | 9,13,918 | 330.91 | 3.61% | 0.14%↑ |
| Glaxosmithkline Pharmaceuticals Ltd. | Healthcare | 10,29,460 | 285.09 | 3.11% | -0.20%↓ |
| Ipca Laboratories Ltd. | Healthcare | 13,64,742 | 262.99 | 2.87% | 0.03%↑ |
| Max Healthcare Institute Ltd. | Healthcare | 26,58,082 | 247.15 | 2.70% | -0.22%↓ |
| Vijaya Diagnostic Centre Ltd. | Healthcare | 16,71,618 | 240.33 | 2.62% | -0.06%↓ |
| Medplus Health Services Ltd. | Healthcare | 35,45,229 | 232.18 | 2.53% | 0.02%↑ |
| Gland Pharma Ltd. | Healthcare | 8,00,549 | 232.11 | 2.53% | 0.09%↑ |
| Abbott India Ltd. | Healthcare | 78,546 | 213.06 | 2.32% | 0.19%↑ |
| Piramal Pharma Ltd. | Healthcare | 99,37,272 | 205.22 | 2.24% | -0.01%↓ |
| Thyrocare Technologies Ltd. | Healthcare | 38,37,967 | 205.01 | 2.24% | -0.21%↓ |
| Dr. Lal Pathlabs Ltd. | Healthcare | 10,00,578 | 198.81 | 2.17% | 0.13%↑ |
| Alkem Laboratories Ltd. | Healthcare | 3,23,678 | 167.13 | 1.82% | 0.00% |
| Sector | 30 Sep 2026 | 31 Aug 2026 | 31 Jul 2026 | 30 Jun 2026 | 31 May 2026 | 30 Apr 2026 |
|---|---|---|---|---|---|---|
| Healthcare | 97.31% | 97.99% | 97.32% | 97.64% | 97.98% | 98.70% |
31.6 / 100
Weighted average Value score is 31.6. This indicates that portfolio is relatively reasonably valued using composite of value measures.
69.6 / 100
Weighted average Price Momentum score is 69.6. This indicates that portfolio has average momentum using composite of momentum measures.
86.8 / 100
Weighted average Quality score is 86.8. This indicates that portfolio has high quality using composite of quality measures.
75.1 / 100
Weighted average QVM score is 75.1. This indicates that portfolio has high QVM score and hence could be considered for investment.
